Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: May 9, 2025
Date Accepted: Jul 22, 2025

The final, peer-reviewed published version of this preprint can be found here:

Uptake of the Second Dose of the Measles Vaccine and Its Determinants Among Children Aged Less Than 5 Years: Systematic Review and Meta-Analysis

Adisu MA, Habtie TE, Kitaw TA, Zemariam AB

Uptake of the Second Dose of the Measles Vaccine and Its Determinants Among Children Aged Less Than 5 Years: Systematic Review and Meta-Analysis

JMIR Public Health Surveill 2025;11:e77195

DOI: 10.2196/77195

PMID: 40864500

PMCID: 12423608

Uptake and determinants of the Second Dose of Measles Vaccine among under-five Children in Ethiopia: A Systematic Review and Meta-Analysis

  • Molalign Aligaz Adisu; 
  • Tesfaye Engdaw Habtie; 
  • Tegene Atamenta Kitaw; 
  • Alemu Birara Zemariam

ABSTRACT

Background:

Ethiopia is faced with poor second dose Measles vaccine uptake (MCV2) leading to recurrent outbreaks. This meta-analysis and systematic review aim at combining evidence for MCV2 uptake in Ethiopia and its determinants to inform interventions for increased vaccination uptake and control of public health challenges.

Objective:

To determine the pooled uptake of second dose measles vaccine among under-five children in Ethiopia and to examine determinant factors, through a systematic review and meta-analysis of published studies.

Methods:

This review examined observational quantitative research on second dose measles vaccination among children in Ethiopia, utilizing databases such as PubMed Central, Cochrane Library, Web of Science, Scopus, MEDLINE, and Embase. The quality of included studies was assessed using the Newcastle-Ottawa Scale. Heterogeneity was evaluated with I² statistics and Cochran's Q test, while analysis employed a random-effects model. Publication bias was assessed through funnel plots, Egger's test, and non-parametric trim-and-fill tests.

Results:

The overall second-dose measles vaccine uptake among under-five children in Ethiopia was only 34.4% (95% CI: 18.8%–49.9%). Significant determinants of second dose measles vaccine uptake included high maternal education (AOR: 3.31, 95% CI: 1.32–5.30), attendance at ante-natal care follow-ups (AOR: 2.02, 95% CI: 1.12–2.92), utilization of post-natal care services (AOR: 3.03, 95% CI: 1.77–4.28), reduced waiting times at vaccination sites (AOR: 2.56, 95% CI: 1.98–3.13), good awareness of measles vaccination (AOR: 2.17, 95% CI: 1.59–2.74), and positive perceptions of the vaccine (AOR: 3.58, 95% CI: 1.97–6.30).

Conclusions:

The study found that the uptake of second dose measles vaccine among under-five children in Ethiopia was 34%, which is well below the global and national goal of 95%. Key factors contributing to low coverage include mothers' education levels, use of antenatal and post-natal services, and waiting times at vaccination sites, and mothers' awareness of the measles vaccine. Improving community-based education programs, increasing access to antenatal and postnatal services, reducing waiting times, and raising awareness about immunization all contribute to increasing vaccine uptake.


 Citation

Please cite as:

Adisu MA, Habtie TE, Kitaw TA, Zemariam AB

Uptake of the Second Dose of the Measles Vaccine and Its Determinants Among Children Aged Less Than 5 Years: Systematic Review and Meta-Analysis

JMIR Public Health Surveill 2025;11:e77195

DOI: 10.2196/77195

PMID: 40864500

PMCID: 12423608

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.